NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Total Liabilities

The latest total liabilities for NRSNW is $2.6M as of December 2025. That compares with $2M in the prior-year period — up 29.9% year over year. Investors often review this figure alongside NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NRSNW's total liabilities moved from $2M to $2.6M — a 29.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s operating scale or balance-sheet position.

A total liabilities figure of $2.6M for NRSNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NRSNW's total liabilities ($2.6M), review year-over-year change from $2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.